Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
84.69
0.00 (0.00%)
At close: Aug 20, 2026, 4:00 PM EDT
84.70
+0.01 (0.01%)
Pre-market: Aug 21, 2026, 9:04 AM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$70,970
Profits / Employee
-$844,455
Market Cap
8.98B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 594 | 157 | 35.93% | 594 | 0 |
| Dec 31, 2024 | 437 | 147 | 50.69% | 437 | 0 |
| Dec 31, 2023 | 290 | 80 | 38.10% | 290 | 0 |
| Dec 31, 2022 | 210 | 67 | 46.85% | 210 | 0 |
| Dec 31, 2021 | 143 | 50 | 53.76% | 143 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Immunovant | 315 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
CRNX News
- 17 days ago - Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Crinetics Pharmaceuticals Earnings release: Q2 2026 - Filings
- 17 days ago - Crinetics Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 21 days ago - Crinetics Pharmaceuticals Proxy statement: Proxy filing - Filings
- 24 days ago - Crinetics downgraded to Neutral from Buy at UBS - TheFly
- 4 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI) - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 weeks ago - Crinetics Pharmaceuticals Slides: Corporate presentation - Filings